PharmaJet’s Needle-free intradermal (ID) injection device (“Tropis® ID”) will be evaluated as delivery system for the tuberculin skin test (TST) in a clinical study conducted by REDE-TB. The study ...

(Corrects to fix typo in the headline) July 16 (Reuters) - Serum Institute of India said on Thursday it would manufacture an ...

A new DNA vaccine delivered through a simple nose spray could give the immune system a powerful new weapon against tuberculosis (TB), helping eliminate bacteria that can hide from antibiotics and ...

The novel vaccine candidate, M72/AS01E, has been in development for two decades and is currently in a late-stage clinical trial.

Add Yahoo as a preferred source to see more of our stories on Google. Tuberculosis, or TB, is a disease that infects nearly 11 million people worldwide, killing some 1.25 million of them every year, ...

The World Health Organization ( WHO ) has labelled tuberculosis as the world's leading infectious disease killer. With more ...

A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can ...

The MarketWatch News Department was not involved in the creation of this content. -- PharmaJet's Needle-free intradermal (ID) injection device ("Tropis(R) ID") will be evaluated as delivery system for ...

PharmaJet ®, a company focused on improving the performance and outcomes of injectables through needle-free injection technology, announced that its partner, Brazilian Tuberculosis Research Network ...